Panel Backs FDA’s Suggestion Of Class II Stapler Status

A US FDA panel unanimously agreed that surgical staplers should be reclassified into class II on 30 May, backing FDA recommendations.

skin-stapler

More from Regulation

More from Policy & Regulation